Keenova Therapeutics to Report Second Quarter 2026 Financial Results on August 11, 2026

Rhea-AI Summary

Keenova Therapeutics (NYSE: MNK) announced it will report its second quarter 2026 financial results on Tuesday, August 11, 2026, before the market opens. On the same day, the company will host an earnings conference call at 8:00 a.m. ET, accessible via webcast and pre-registered dial-in.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DUBLIN, July 30, 2026 /PRNewswire/ -- Keenova Therapeutics plc, a leading developer and manufacturer of branded therapeutics, announced today that it will report its second quarter 2026 financial results on Tuesday, August 11, 2026, before market open. The Company will host a conference call on the same day at 8:00 a.m. ET.

The audio webcast may be accessed through the Investor Relations section of the Company's website at investor.keenova.com under Events & Presentations or through this link. To access the call through a conference line, participants can register here to receive a dial-in number and personalized PIN to participate in the call. Participants are advised to join 10 minutes prior to the scheduled start time. A replay of the webcast will be available following the event.

About Keenova

Keenova Therapeutics is a leading U.S.-focused branded therapeutics company that strives to help patients with rare or unaddressed conditions live happier and healthier lives.

Keenova's rare disease capabilities underpin our diversified brands portfolio, which is focused across a wide range of specialty therapeutic areas of significant unmet need. These include rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology, and neonatal respiratory critical care.

Headquartered in Dublin, Ireland, Keenova benefits from a strong U.S. manufacturing footprint with facilities in Louisiana, New Jersey, New York, Pennsylvania, and Wisconsin. To learn more, please visit www.keenova.com.

Keenova uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the U.S. Securities and Exchange Commission ("SEC") disclosing the same information. Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations page of the website.

Contacts

Investors

investor.relations@keenova.com

Media

media.relations@keenova.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/keenova-therapeutics-to-report-second-quarter-2026-financial-results-on-august-11-2026-302838274.html

SOURCE Keenova Therapeutics

FAQ

When will Keenova Therapeutics (MNK) report its Q2 2026 earnings?

Keenova Therapeutics (MNK) will report its Q2 2026 financial results on Tuesday, August 11, 2026, before market open. According to Keenova Therapeutics, the release will be followed by an earnings conference call later that morning.

What time is the Keenova Therapeutics (MNK) Q2 2026 earnings call on August 11, 2026?

The Keenova Therapeutics (MNK) Q2 2026 earnings conference call is scheduled for 8:00 a.m. Eastern Time on August 11, 2026. According to Keenova Therapeutics, participants are advised to join about 10 minutes before the scheduled start time.

How can investors access the Keenova Therapeutics (MNK) Q2 2026 earnings webcast?

Investors can access the Keenova Therapeutics (MNK) Q2 2026 earnings audio webcast via the Investor Relations section at investor.keenova.com under Events & Presentations. According to Keenova Therapeutics, an online webcast link will be available for live listening.

How do I join the Keenova Therapeutics (MNK) Q2 2026 earnings call by phone?

To join the Keenova Therapeutics (MNK) Q2 2026 earnings call by phone, participants must register online to receive a dial-in number and personalized PIN. According to Keenova Therapeutics, this registration is required to access the conference line.

Will a replay of the Keenova Therapeutics (MNK) Q2 2026 earnings webcast be available?

Yes, a replay of the Keenova Therapeutics (MNK) Q2 2026 earnings webcast will be available after the event. According to Keenova Therapeutics, investors can listen to the archived audio through the company’s Investor Relations website following the live call.

Where is the Keenova Therapeutics (MNK) Q2 2026 earnings information hosted online?

Keenova Therapeutics (MNK) Q2 2026 earnings information and webcast access are hosted in the Investor Relations section at investor.keenova.com, under Events & Presentations. According to Keenova Therapeutics, this page provides links for the live call and replay.